Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC Supplementation in G6PD Deficiency
NCT02937376Phase 1Unknown
- Sponsor
- University of Thessaly
- Start
- Feb 2023
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of acetylcysteine in glucose-6-phosphate dehydrogenase deficiency (2 arms), sponsored by University of Thessaly. Primary endpoint: Change in redox status after exercise. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
glucose-6-phosphate dehydrogenase deficiency
Beyond the preview
Go deeper on NCT02937376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02937376.